Login / Signup

The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis.

Chelsea KotchStephanie J SiKavita DesaiPhilippe CaminadaFrancesco Maria Lo RussoYimei LiGrant T LiuRobert A AveryMichael J Fisher
Published in: Journal of neuro-oncology (2023)
Increased gadolinium-enhancement independent of a concurrent increase in tumor size on MRI should not be used as a marker of NF1-OPG progression and does not appear to be associated with visual decline or initiation of chemotherapy.
Keyphrases